Variant report

Variant	esv3364812
Chromosome Location	chr15:40414858-40427614
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:51)
CpG islands
(count:733)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:51 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr15:40417275-40417528	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr15:40424981-40425100	HepG2	liver:	n/a	n/a
3	CHD2	chr15:40417229-40417422	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTBP2	chr15:40417230-40417460	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr15:40416283-40416319	Kidney_OC	kidney:	n/a	n/a
6	CTCF	chr15:40416913-40416984	GM13976	blood:	n/a	n/a
7	CTCF	chr15:40415374-40415452	GM13976	blood:	n/a	n/a
8	CTCF	chr15:40417297-40417305	MCF-7	breast:	n/a	n/a
9	CTCF	chr15:40417256-40417268	MCF-7	breast:	n/a	n/a
10	CTCF	chr15:40427179-40427252	Spleen_OC	spleen:	n/a	n/a
11	CTCF	chr15:40418370-40418618	H1-hESC	embryonic stem cell:	n/a	n/a
12	CUX1	chr15:40418280-40418587	K562	blood:	n/a	n/a
13	CUX1	chr15:40423125-40423611	K562	blood:	n/a	n/a
14	CUX1	chr15:40421909-40422020	K562	blood:	n/a	n/a
15	CUX1	chr15:40417879-40418022	K562	blood:	n/a	n/a
16	CUX1	chr15:40422408-40422523	K562	blood:	n/a	n/a
17	EP300	chr15:40417197-40417569	H1-hESC	embryonic stem cell:	n/a	chr15:40417318-40417327
18	GATA3	chr15:40417187-40417534	T-47D	breast:	n/a	chr15:40417203-40417213 chr15:40417459-40417469
19	HDAC2	chr15:40417286-40417590	H1-hESC	embryonic stem cell:	n/a	n/a
20	MYC	chr15:40417226-40417379	MCF-7	breast:	n/a	n/a
21	MYC	chr15:40417220-40417224	MCF-7	breast:	n/a	n/a
22	MYC	chr15:40417309-40417383	MCF-7	breast:	n/a	n/a
23	NR3C1	chr15:40415242-40415445	A549	lung:	n/a	chr15:40415316-40415331
24	NR3C1	chr15:40415217-40415563	A549	lung:	n/a	chr15:40415316-40415331
25	NR3C1	chr15:40415087-40415547	A549	lung:	n/a	chr15:40415316-40415331
26	NR3C1	chr15:40415198-40415519	A549	lung:	n/a	chr15:40415316-40415331
27	POLR2A	chr15:40416696-40417544	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr15:40416421-40416468	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr15:40416939-40417442	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr15:40422283-40422295	Gliobla	brain:	n/a	n/a
31	POLR2A	chr15:40417173-40417286	MCF-7	breast:	n/a	n/a
32	POLR2A	chr15:40416889-40417556	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr15:40417088-40417433	H1-hESC	embryonic stem cell:	n/a	n/a
34	POLR2A	chr15:40416158-40416237	H1-hESC	embryonic stem cell:	n/a	n/a
35	POLR2A	chr15:40416899-40417512	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr15:40416308-40416347	MCF-7	breast:	n/a	n/a
37	RAD21	chr15:40417193-40417613	H1-hESC	embryonic stem cell:	n/a	n/a
38	REST	chr15:40417172-40417473	H1-hESC	embryonic stem cell:	n/a	n/a
39	SIN3AK20	chr15:40417072-40417779	MCF-7	breast:	n/a	n/a
40	SP1	chr15:40417078-40417560	H1-hESC	embryonic stem cell:	n/a	n/a
41	SP1	chr15:40417189-40417520	H1-hESC	embryonic stem cell:	n/a	n/a
42	TAF1	chr15:40416979-40417441	H1-hESC	embryonic stem cell:	n/a	n/a
43	TAF1	chr15:40416850-40417479	H1-hESC	embryonic stem cell:	n/a	n/a
44	TCF12	chr15:40417301-40417562	H1-hESC	embryonic stem cell:	n/a	chr15:40417350-40417360
45	TEAD4	chr15:40417082-40417571	H1-hESC	embryonic stem cell:	n/a	n/a
46	TEAD4	chr15:40417162-40417498	H1-hESC	embryonic stem cell:	n/a	n/a
47	YY1	chr15:40417191-40417578	H1-hESC	embryonic stem cell:	n/a	n/a
48	YY1	chr15:40417295-40417560	H1-hESC	embryonic stem cell:	n/a	n/a
49	ZNF217	chr15:40417183-40417620	MCF-7	breast:	n/a	n/a
50	ZNF274	chr15:40422621-40423293	K562	blood:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:40423556-40423606	HPAEpiC	pulmonary alveolar:	n/a
2	chr15:40423556-40423606	HPAEpiC	pulmonary alveolar:	n/a
3	chr15:40421135-40421185	GM12891	blood:	n/a
4	chr15:40417564-40417614	MCF10A-Er-Src	breast:	n/a
5	chr15:40417564-40417614	HUVEC	blood vessel:	n/a
6	chr15:40421080-40421130	HNPCEpiC	eye:	n/a
7	chr15:40421135-40421185	K562	blood:	n/a
8	chr15:40423298-40423348	ECC-1	luminal epithelium:	n/a
9	chr15:40423445-40423495	NHBE	bronchial:	n/a
10	chr15:40423556-40423606	Hepatocyte	liver:	n/a
11	chr15:40421005-40421055	SK-N-SH_RA	brain:	n/a
12	chr15:40421005-40421055	HEEpiC	esophagus:	n/a
13	chr15:40421005-40421055	H1-hESC	embryonic stem cell:	embryo
14	chr15:40423445-40423495	NHDF-neo	bronchial:	n/a
15	chr15:40426006-40426056	T-47D	breast:	n/a
16	chr15:40423298-40423348	AG10803	skin:	n/a
17	chr15:40421005-40421055	HRE	kidney:	n/a
18	chr15:40421005-40421055	LNCaP	prostate:	n/a
19	chr15:40426006-40426056	HEEpiC	esophagus:	n/a
20	chr15:40421135-40421185	T-47D	breast:	n/a
21	chr15:40422219-40422269	NH-A	brain:	n/a
22	chr15:40417564-40417614	AG04450	lung:	fetal
23	chr15:40421080-40421130	GM12892	blood:	n/a
24	chr15:40421080-40421130	GM19239	blood:	n/a
25	chr15:40423298-40423348	HAEpiC	amniotic membrane:	n/a
26	chr15:40423445-40423495	AG09309	skin:	n/a
27	chr15:40426063-40426113	SK-N-SH	brain:	n/a
28	chr15:40417564-40417614	HPAEpiC	pulmonary alveolar:	n/a
29	chr15:40421005-40421055	NH-A	brain:	n/a
30	chr15:40417564-40417614	K562	blood:	n/a
31	chr15:40421080-40421130	HepG2	liver:	n/a
32	chr15:40417564-40417614	SK-N-MC	brain:	n/a
33	chr15:40422098-40422148	BJ	skin:	n/a
34	chr15:40425922-40425972	CMK	blood:	n/a
35	chr15:40421135-40421185	MCF-7	breast:	n/a
36	chr15:40421135-40421185	HEK293	kidney:	embryo
37	chr15:40422098-40422148	BE2_C	brain:	n/a
38	chr15:40423298-40423348	GM12878	blood:	n/a
39	chr15:40421135-40421185	IMR90	lung:	fetal
40	chr15:40421135-40421185	SK-N-MC	brain:	n/a
41	chr15:40421135-40421185	HPAEpiC	pulmonary alveolar:	n/a
42	chr15:40422219-40422269	GM12891	blood:	n/a
43	chr15:40417564-40417614	SK-N-SH	brain:	n/a
44	chr15:40422219-40422269	HRE	kidney:	n/a
45	chr15:40426063-40426113	PrEC	prostate:	n/a
46	chr15:40421005-40421055	AG04449	skin:	fetal
47	chr15:40425922-40425972	AG04450	lung:	fetal
48	chr15:40426006-40426056	BE2_C	brain:	n/a
49	chr15:40423556-40423606	GM06990	blood:	n/a
50	chr15:40426006-40426056	HPAEpiC	pulmonary alveolar:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:40408512..40410624-chr15:40413649..40415677,2	K562	blood:
2	chr15:40396612..40398136-chr15:40423980..40425844,2	K562	blood:
3	chr15:40401545..40403249-chr15:40412474..40415066,2	MCF-7	breast:
4	chr15:40423124..40425673-chr15:40427954..40430256,2	K562	blood:
5	chr15:40389070..40391081-chr15:40419316..40421072,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000259239	TF binding region
ENSG00000259239	CpG island

Extended variants
information (count: 252 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:252 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs377360150	chr15:40414874-40414875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs193280834	chr15:40414941-40414942	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs57543880	chr15:40414948-40414949	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs148569038	chr15:40414982-40414983	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs568846331	chr15:40415021-40415022	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs185484189	chr15:40415097-40415098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs55730121	chr15:40415114-40415115	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs372779773	chr15:40415137-40415138	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs192207967	chr15:40415166-40415167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs574828792	chr15:40415249-40415250	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs535805	chr15:40415288-40415289	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs534312111	chr15:40415300-40415301	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs62019962	chr15:40415306-40415307	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs553834768	chr15:40415372-40415373	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs577192735	chr15:40415378-40415379	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs546486966	chr15:40415400-40415401	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs563162855	chr15:40415405-40415406	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs368703477	chr15:40415423-40415424	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs576838840	chr15:40415426-40415427	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs542430133	chr15:40415434-40415435	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs562313772	chr15:40415457-40415458	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs529707573	chr15:40415523-40415524	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs113859843	chr15:40415530-40415531	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs183989860	chr15:40415535-40415536	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs188395770	chr15:40415670-40415671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs532479513	chr15:40415682-40415683	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs531965288	chr15:40415686-40415687	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs551782492	chr15:40415693-40415694	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs568808837	chr15:40415732-40415733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs376631343	chr15:40415742-40415743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs548042603	chr15:40415745-40415746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs181173259	chr15:40415782-40415783	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs373125570	chr15:40415786-40415787	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs534011621	chr15:40415791-40415792	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs371165629	chr15:40415807-40415808	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs377582436	chr15:40415827-40415828	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs554258200	chr15:40415828-40415829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs577304586	chr15:40415830-40415831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs560465424	chr15:40415871-40415872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs9635304	chr15:40415932-40415933	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs556632429	chr15:40415960-40415961	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs186060851	chr15:40415961-40415962	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs542541830	chr15:40415979-40415980	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs555650336	chr15:40416009-40416010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs572614925	chr15:40416022-40416023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs541296897	chr15:40416025-40416026	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs58995872	chr15:40416042-40416043	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs61436050	chr15:40416053-40416054	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs545384264	chr15:40416083-40416084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs542804693	chr15:40416096-40416097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
HDAC8	0	CNVD
NIPBL	0	CNVD
RAD21	0	CNVD
SMC1A	0	CNVD
SMC3	0	CNVD
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Angelman syndrome	16183798	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	17053054	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164920	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21129771	CNVD
Breast cancer	21045282	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	22032731	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Pancreatic cancer	17952125	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22150418	CNVD
Autosomal-recessive limb girdle muscular dystrophy	22150418	CNVD

Chromatin state (count:95 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:40402000-40418600	Weak transcription	Right Atrium	heart
2	chr15:40408400-40416800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr15:40408400-40417000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr15:40408600-40416600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
5	chr15:40409200-40415200	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr15:40411400-40416600	Weak transcription	NHEK	skin
7	chr15:40414000-40415200	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr15:40414000-40415600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr15:40414000-40415600	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr15:40414200-40415000	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr15:40414200-40415000	Enhancers	HUES6 Cell Line	embryonic stem cell
12	chr15:40414200-40415000	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr15:40414200-40415400	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr15:40414200-40415600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr15:40414200-40416000	Enhancers	Placenta	Placenta
16	chr15:40414400-40415400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr15:40414400-40415600	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr15:40414600-40415600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr15:40414600-40415600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr15:40414600-40416600	Weak transcription	H9 Cell Line	embryonic stem cell
21	chr15:40414800-40416600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr15:40415000-40415400	Weak transcription	HUES48 Cell Line	embryonic stem cell
23	chr15:40415000-40415400	Weak transcription	HUES6 Cell Line	embryonic stem cell
24	chr15:40415000-40415600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr15:40415000-40416600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr15:40415200-40415400	Enhancers	Fetal Muscle Leg	muscle
27	chr15:40415200-40415400	Enhancers	Rectal Mucosa Donor 31	rectum
28	chr15:40415200-40415600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr15:40415200-40415600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
30	chr15:40415200-40418000	Enhancers	H1 Cell Line	embryonic stem cell
31	chr15:40415400-40415600	Enhancers	HUES48 Cell Line	embryonic stem cell
32	chr15:40415400-40415600	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr15:40415400-40415800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr15:40415400-40416200	Weak transcription	Rectal Mucosa Donor 31	rectum
35	chr15:40415400-40416800	Weak transcription	HUES64 Cell Line	embryonic stem cell
36	chr15:40415400-40416800	Weak transcription	HMEC	breast
37	chr15:40415600-40416200	Weak transcription	Primary neutrophils fromperipheralblood	blood
38	chr15:40415600-40416400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
39	chr15:40415600-40416600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr15:40415600-40416600	Weak transcription	HUES48 Cell Line	embryonic stem cell
41	chr15:40415600-40416800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr15:40415600-40417000	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr15:40416000-40416400	Weak transcription	Placenta	Placenta
44	chr15:40416200-40417000	Enhancers	Primary neutrophils fromperipheralblood	blood
45	chr15:40416400-40417800	Enhancers	Placenta	Placenta
46	chr15:40416400-40418600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr15:40416600-40417000	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr15:40416600-40417000	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr15:40416600-40417000	Enhancers	iPS-20b Cell Line	embryonic stem cell
50	chr15:40416600-40417800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links